Rituximab in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia
NCT02461316
·
clinicaltrials.gov ↗
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Lymphocytic Leukemia, Chronic, Chronic Lymphocytic Leukemia, Cancer
Interventions
OTHER:
No intervention
Sponsor
Hoffmann-La Roche